Fundamental Analysis of Brickell Biotech Inc - Growth / Value Index


BBI - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Good Score of 68.75
   Price to Book Ratio is 0.0024 indicating that it is undervalued.
   Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -0.0016 -0.0009 -73.58 %
Price to Book 0.0024 0.0014 256.94 % 0.0037
Price to Sales 0.0103 0.088 1377.58 %
Enterprise Value to EBITDA Multiple 0.812 0.680 -51.97 %


BBI - Profitability Highlights

Profitability Analysis

   Piotroski F Score - Stable Value of 4.0
   Steady Growth in EPS for last four quarters
   Tsr Profitability Index - Very Poor Score of 5.00
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -151.03 -158.49 -105.64 % -7.34
Return On Asset -122.17 -132.83 -113.63 % -6.20
Net Profit Margin -643.48 -9770.79 -751.26 % -26.58
Operating Profit Margin -657.53 -9961.39 -765.26 % -33.79
EBITDA Margin -642.67 -9748.27 -749.70 % -26.40


Highlights
Market Cap2587.43 K
Enterprise Value-24227.57 K
Price/Book TTM0.0024
Outstanding Share2873.96 K
Float/ Outstanding Share94.07%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score4.00
Altman Z Score-9.89
Sloan Ratio-0.111
Peter Lynch Fair Value0


BBI - Growth Highlights

Growth Analysis

   YoY Net Margin Jump by 751.26%
   Annual sales in last 3 years is trending down
   Companies' sales dropped by 77.83 % from last year
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 4643.00 K 77.83 % 4590.22 %
Gross Profit 4643.00 K 22073.44 % 4590.22 %
EBITDA -29839.00 K 88.41 % 87.88 %
Net Profit -29877.00 K 88.75 % 87.81 %
EPS -562.38 42.39 % NA


BBI - Stability Highlights

Stability Analysis

   Paid More Than 50% of Debt, Heading towards debt free
   Debt to equity ratio has decreased and is lowest in last three years
   Cash ratio of 5.59
   Altman Z Score of -9.89 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -571.09
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.0028 -85.29 % 0.0023
Cash Ratio 5.59 17.91 %
Quick Ratio 0 0 % 6.36
Shareholders Equity 83.81 3.89 %
Debt to EBITDA -0.0018 92.83 %


Historical Valuation Ratios of Brickell Biotech Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Brickell Biotech Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Brickell Biotech Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Brickell Biotech Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)